Mycophenolate Mofetil for the Treatment of Autoimmune Hepatitis in Patients Refractory or Intolerant to Conventional Therapy | Zendy

Kaveh Sharzehi | Zendy; Mary Ann Huang | Zendy; Ian Schreibman | Zendy; Kimberly Brown | Zendy

Open Access

Mycophenolate Mofetil for the Treatment of Autoimmune Hepatitis in Patients Refractory or Intolerant to Conventional Therapy

Author(s) -

Kaveh Sharzehi,

Mary Ann Huang,

Ian Schreibman,

Kimberly Brown

Publication year - 2010

Publication title -

canadian journal of gastroenterology

Language(s) - English

Resource type - Journals

eISSN - 1916-7237

pISSN - 0835-7900

DOI - 10.1155/2010/891252

Subject(s) - medicine , autoimmune hepatitis , refractory (planetary science) , azathioprine , gastroenterology , mycophenolate , mycophenolic acid , hepatitis , hepatitis c , disease , transplantation , physics , astrobiology

Autoimmune hepatitis is characterized by hepatocellular inflammation often progressing to cirrhosis. Standard treatment consists of corticosteroids and azathioprine. For the 20% of patients with refractory disease or those who are intolerant to medication, there is no standardized treatment.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research